跳至主要内容
临床试验/CTRI/2025/02/080987
CTRI/2025/02/080987尚未招募4 期

Comparative Study Of Efficacy And Safety Of Intravenous Ferric Carboxymaltose And Iron Sucrose In The Management Of Postpartum Anemia

Sikkim Manipal Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月3日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Rise in hemoglobin and Serum Ferritin values

研究概览

简要总结

Comparative Study Of Efficacy And Safety Of Intravenous Ferric Carboxymaltose And Iron Sucrose In The Management Of Postpartum Anemia,

Summary- In this prospective interventional study spanning for a time period of 1 year, 60 patients fulfilling the criteria will be selected and then divided into 2 groups. Group A will be given parenteral ferric caboxymaltose while group B will recieve parenteral Iron sucrose.

研究设计

研究类型
Interventional
分配方式
Other

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • All postpartum feamle consenting for study having hemoglobin 7 to 9.9g/dl Iron deficiency anemia diagnosed by complete blood count with peripheral blood smear and serum ferritin levels.

排除标准

  • Allergic to parenteral Iron Patient who did not give consent.

结局指标

主要结局

Rise in hemoglobin and Serum Ferritin values

时间窗: 1 YEAR

次要结局

  • Adverse Effects & Safety Profile(1 YEAR)

研究者

发起方
Sikkim Manipal Institute of Medical Sciences
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Ratnpriya

Sikkim Manipal Institute Of Medical Sciences, Gangtok

研究点 (1)

Loading locations...

相似试验